Transcription of Annual Report - General Electric
{{id}} {{{paragraph}}}
2019 Annual ReportFORWARD-LOOKING STATEMENTSSome of the information we provide in this document is forward-looking and therefore could change over time to reflect changes in the environment in which GE competes. For details on the uncertainties that may cause our actual results to be materially different than those expressed in our forward-looking statements, see We do not undertake to update our forward-looking FINANCIAL MEASURESWe sometimes use information derived from consolidated financial data but not presented in our financial statements prepared in accordance with generally accepted accounting principles (GAAP). Certain of these data are considered non-GAAP financial measures under the Securities and Exchange Commission rules. These non-GAAP financial measures supplement our GAAP disclosures and should not be considered an alternative to the GAAP measure. The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures can be found on pages 43-49 of the Management s Discussion and Analysis within our Form 10-K and in GE s fourth-quarter 2019 earnings materials posted to , as FRONT COVERW ysheka Austin, Senior Operations Manager, works on a combustion unibody for GE Gas Power s 7HA gas turbine in Greenville, South Jones, a Development Assembly Mechanic, performs a perfection review on the propulsor for GE Aviation s GE9X
equity vs. 5.7x in 2018. % Agreed to sell BioPharma, part of GE Healthcare, to Danaher for ~$21 billion. % Completed spin-off and subsequent merger of GE Transportation with Wabtec and exited stake for ~$6 billion of total proceeds. % Executed market’s largest secondary offering in 2019 to reduce Baker Hughes
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}